GSK.L vs. EQQQ.L
Compare and contrast key facts about GlaxoSmithKline plc (GSK.L) and Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L).
EQQQ.L is a passively managed fund by Invesco that tracks the performance of the NASDAQ-100 Index. It was launched on Dec 2, 2002.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK.L or EQQQ.L.
Key characteristics
| GSK.L | EQQQ.L | |
|---|---|---|
| YTD Return | 6.03% | 17.09% |
| 1Y Return | 3.26% | 25.29% |
| 3Y Return (Ann) | 6.17% | 12.61% |
| 5Y Return (Ann) | 2.46% | 20.84% |
| 10Y Return (Ann) | 5.95% | 21.18% |
| Sharpe Ratio | 0.19 | 1.61 |
| Sortino Ratio | 0.37 | 2.19 |
| Omega Ratio | 1.05 | 1.29 |
| Calmar Ratio | 0.19 | 2.12 |
| Martin Ratio | 0.46 | 6.37 |
| Ulcer Index | 8.36% | 4.06% |
| Daily Std Dev | 20.34% | 15.98% |
| Max Drawdown | -50.10% | -33.75% |
| Current Drawdown | -15.98% | -3.21% |
Correlation
The correlation between GSK.L and EQQQ.L is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK.L vs. EQQQ.L - Performance Comparison
In the year-to-date period, GSK.L achieves a 6.03% return, which is significantly lower than EQQQ.L's 17.09% return. Over the past 10 years, GSK.L has underperformed EQQQ.L with an annualized return of 5.95%, while EQQQ.L has yielded a comparatively higher 21.18% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK.L vs. EQQQ.L - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK.L) and Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GSK.L vs. EQQQ.L - Dividend Comparison
GSK.L's dividend yield for the trailing twelve months is around 4.01%, more than EQQQ.L's 0.41% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK.L GlaxoSmithKline plc | 4.01% | 3.84% | 4.66% | 4.93% | 5.90% | 4.45% | 5.31% | 5.99% | 4.88% | 5.77% | 5.76% | 5.62% |
EQQQ.L Invesco EQQQ NASDAQ-100 UCITS ETF | 0.41% | 0.39% | 0.56% | 0.25% | 0.41% | 0.56% | 0.63% | 0.67% | 0.77% | 0.72% | 1.01% | 0.95% |
Drawdowns
GSK.L vs. EQQQ.L - Drawdown Comparison
The maximum GSK.L drawdown since its inception was -50.10%, which is greater than EQQQ.L's maximum drawdown of -33.75%. Use the drawdown chart below to compare losses from any high point for GSK.L and EQQQ.L. For additional features, visit the drawdowns tool.
Volatility
GSK.L vs. EQQQ.L - Volatility Comparison
GlaxoSmithKline plc (GSK.L) has a higher volatility of 6.45% compared to Invesco EQQQ NASDAQ-100 UCITS ETF (EQQQ.L) at 3.44%. This indicates that GSK.L's price experiences larger fluctuations and is considered to be riskier than EQQQ.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.